LIVER-TRANSPLANTATION FOR TYPE-IV GLYCOGEN-STORAGE-DISEASE

被引:46
作者
SELBY, R
STARZL, TE
YUNIS, E
BROWN, BI
KENDALL, RS
TZAKIS, A
机构
[1] UNIV PITTSBURGH,UNIV HLTH CTR PITTSBURGH,CHILDRENS HOSP,DEPT SURG,3601 5TH AVE,PITTSBURGH,PA 15213
[2] UNIV PITTSBURGH,UNIV HLTH CTR PITTSBURGH,CHILDRENS HOSP,DEPT PATHOL,PITTSBURGH,PA 15213
[3] MARY BRIDGE CHILDRENS HOSP,TACOMA,WA
[4] WASHINGTON UNIV,SCH MED,DEPT BIOCHEM,ST LOUIS,MO 63110
关键词
D O I
10.1056/NEJM199101033240107
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
TYPE IV glycogen storage disease is a rare autosomal recessive disorder (also called Andersen's disease1 or amylopectinosis) in which the activity of branching enzyme alpha-1, 4-glucan: alpha-1, 4-glucan 6-glucosyltransferase is deficient in the liver as well as in cultured skin fibroblasts and other tissues.2,3 This branching enzyme is responsible for creating branch points in the normal glycogen molecule. In the relative or absolute absence of this enzyme, an insoluble and irritating form of glycogen, an amylopectin-like polysaccharide that resembles plant starch, accumulates in the cells. The amylopectin-like form is less soluble than normal glycogen, with longer outer and inner chains. © 1991, Massachusetts Medical Society. All rights reserved.
引用
收藏
页码:39 / 42
页数:4
相关论文
共 26 条